Lockdown surgery: the impact of coronavirus disease 2019 measures on cardiac cases

Felix Nägele1, Clemens Engler1,2, Michael Graber1

  • 1Department of Cardiac Surgery, Medical University of Innsbruck, Austria.

Insights

During the COVID-19 pandemic, cardiac surgery waitlists grew. Despite a 29% drop in procedures and sicker patients during lockdown, outcomes remained stable due to careful patient selection.

Area of Science:

  • Cardiology
  • Surgical Outcomes
  • Pandemic Preparedness

Background:

  • The coronavirus disease 2019 (COVID-19) pandemic necessitated rationing of medical resources, leading to extended wait times for surgical procedures.
  • Understanding the impact of public health interventions like lockdowns on surgical care is crucial for future pandemic planning.

Purpose of the Study:

  • To assess the impact of lockdown periods on the volume, characteristics, and outcomes of cardiac surgery.
  • To compare cardiac surgery data during the first COVID-19 lockdown with pre-lockdown periods and previous years.

Main Methods:

  • A single-centre, cross-sectional descriptive observational study was conducted at the Department of Cardiac Surgery, Medical University of Innsbruck.
  • Data from a quality management system were prospectively collected and retrospectively analyzed, comparing lockdown periods with the preceding 3 years.
  • Primary objective: compare weekly open-heart procedures pre-lockdown vs. during lockdown. Secondary objectives: analyze case characteristics and outcomes.

Main Results:

  • A significant 29% reduction in weekly cardiac surgical procedures was observed during the lockdown period.
  • Patient demographics remained unchanged, but the urgency and severity of cases increased.
  • Despite operating on sicker patients, the surgical case-mix (e.g., valve replacements, bypass grafts) and patient outcomes remained stable.

Conclusions:

  • The quality of open-heart procedures was maintained during the COVID-19 lockdown.
  • Rational patient selection was key to preserving surgical quality despite increased patient acuity and symptom severity.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
45
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
56
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
42
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
46
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
50
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
75